Skip to main content
Erschienen in: Internal and Emergency Medicine 7/2023

05.09.2023 | EM - ORIGINAL

Clinical utility of routine investigations and risk factors of end-organ damage in asymptomatic severe hypertension

verfasst von: Noman Ali, Umaira Aftab, Salman Muhammad Soomar, Hafsa Tareen, Uzma Rahim Khan, Badar Afzal Khan, Junaid Abdul Razzak

Erschienen in: Internal and Emergency Medicine | Ausgabe 7/2023

Einloggen, um Zugang zu erhalten

Abstract

Asymptomatic severe hypertension is defined as systolic blood pressure of ≥ 180 mmHg or diastolic blood pressure of ≥ 120 mmHg without signs and symptoms of end-organ damage or dysfunction. Literature shows that around 5% of the patients with severe asymptomatic hypertension had acute hypertension-related end-organ damage. This study aimed to determine the clinical utility of routine investigations and risk factors of end-organ damage in patients presented to the emergency department with  asymptomatic severe hypertension. This single-center, cross-sectional study was conducted at the emergency department of the Aga Khan University Hospital, Karachi, Pakistan, from January 2018 to December 2020. All adult patients (age ≥ 18 years) presented to the emergency department with a systolic blood pressure of ≥ 180 or diastolic blood pressure of ≥ 120 mmHg without any signs and symptoms of end-organ damage (e.g., chest pain, unilateral limb or facial weakness, or hemiplegia, altered mental status, shortness of breath, decreased urine output, and sudden-onset of severe headache) were included. Routine investigations were analyzed to detect end-organ damage, including complete blood count, basic metabolic panel, urine detailed report, electrocardiogram, and troponin-I. Multivariable binary logistic regression was applied to identify the risk factors of end-organ damage considering the significant p value of ≤ 0.05. A total of 180 patients were presented to the emergency department with asymptomatic severe hypertension during the study period. Among the total patients, 60 patients (33.3%) had abnormal investigation findings; out of them, new-onset end-organ damage was diagnosed in 15 patients (8.3%). The most common end-organ damage was the kidney (73.3%) followed by the heart (26.6%). The multivariable binary logistic regression showed that age of more than 60 years, past medical history of diabetes, ischemic heart disease, and cerebrovascular accident were significantly associated with a higher risk of end-organ damage (p < 0.05). The study identified a higher prevalence of abnormal routine investigations and acute end-organ damage in emergency department patients with asymptomatic severe hypertension compared to high-income countries and suggested a lower threshold for end-organ damage screening in these patients. The current recommendations of foregoing further workup in patients with asymptomatic severe hypertension may need modification for emergency departments in low–middle-income countries if similar associations are replicated in other settings.
Literatur
1.
Zurück zum Zitat Organization WH (2013) A global brief on hypertension: silent killer, global public health crisis: World Health Day 2013. World Health Organization Organization WH (2013) A global brief on hypertension: silent killer, global public health crisis: World Health Day 2013. World Health Organization
2.
Zurück zum Zitat Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H et al (2012) A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the global burden of disease study 2010. The lancet 380(9859):2224–2260CrossRef Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H et al (2012) A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the global burden of disease study 2010. The lancet 380(9859):2224–2260CrossRef
3.
Zurück zum Zitat Mills KT, Bundy JD, Kelly TN, Reed JE, Kearney PM, Reynolds K et al (2016) Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries. Circulation 134(6):441–450CrossRefPubMedPubMedCentral Mills KT, Bundy JD, Kelly TN, Reed JE, Kearney PM, Reynolds K et al (2016) Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries. Circulation 134(6):441–450CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Peters MA, Noonan CM, Rao KD, Edward A, Alonge OO (2022) Evidence for an expanded hypertension care cascade in low-and middle-income countries: a scoping review. BMC Health Serv Res 22(1):1–17CrossRef Peters MA, Noonan CM, Rao KD, Edward A, Alonge OO (2022) Evidence for an expanded hypertension care cascade in low-and middle-income countries: a scoping review. BMC Health Serv Res 22(1):1–17CrossRef
6.
Zurück zum Zitat Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D et al (2020) 2020 International society of hypertension global hypertension practice guidelines. Hypertension 75(6):1334–1357CrossRefPubMed Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D et al (2020) 2020 International society of hypertension global hypertension practice guidelines. Hypertension 75(6):1334–1357CrossRefPubMed
7.
Zurück zum Zitat Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, Dennison Himmelfarb C et al (2018) 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American college of cardiology/American heart association task force on clinical practice guidelines. J Am Coll Cardiol 71(19):e127–e248CrossRefPubMed Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, Dennison Himmelfarb C et al (2018) 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American college of cardiology/American heart association task force on clinical practice guidelines. J Am Coll Cardiol 71(19):e127–e248CrossRefPubMed
8.
Zurück zum Zitat Gauer R (2017) Severe asymptomatic hypertension: evaluation and treatment. Am Fam Physician 95(8):492–500PubMed Gauer R (2017) Severe asymptomatic hypertension: evaluation and treatment. Am Fam Physician 95(8):492–500PubMed
9.
Zurück zum Zitat Wolf SJ, Lo B, Shih RD, Smith MD, Fesmire FM (2013) Clinical policy: critical issues in the evaluation and management of adult patients in the emergency department with asymptomatic elevated blood pressure. Ann Emerg Med 62(1):59–68CrossRefPubMed Wolf SJ, Lo B, Shih RD, Smith MD, Fesmire FM (2013) Clinical policy: critical issues in the evaluation and management of adult patients in the emergency department with asymptomatic elevated blood pressure. Ann Emerg Med 62(1):59–68CrossRefPubMed
10.
Zurück zum Zitat McNaughton CD, Self WH, Zhu Y, Janke AT, Storrow AB, Levy P (2015) Incidence of hypertension-related emergency department visits in the United States, 2006 to 2012. Am J Cardiol 116(11):1717–1723CrossRefPubMedPubMedCentral McNaughton CD, Self WH, Zhu Y, Janke AT, Storrow AB, Levy P (2015) Incidence of hypertension-related emergency department visits in the United States, 2006 to 2012. Am J Cardiol 116(11):1717–1723CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Chobufo MD, Rahman EU, Farah F, Suliman M, Mansoor K, Elhamdani A et al (2020) 10-Year community prevalence and trends of severe asymptomatic hypertension among patients with hypertension in the USA: 2007–2016. Int J Cardiol Hypertens 7:100066CrossRefPubMedPubMedCentral Chobufo MD, Rahman EU, Farah F, Suliman M, Mansoor K, Elhamdani A et al (2020) 10-Year community prevalence and trends of severe asymptomatic hypertension among patients with hypertension in the USA: 2007–2016. Int J Cardiol Hypertens 7:100066CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Adidja NM, Agbor VN, Aminde JA, Ngwasiri CA, Ngu KB, Aminde LN (2018) Non-adherence to antihypertensive pharmacotherapy in Buea, Cameroon: a cross-sectional community-based study. BMC Cardiovasc Disord 18(1):1–9CrossRef Adidja NM, Agbor VN, Aminde JA, Ngwasiri CA, Ngu KB, Aminde LN (2018) Non-adherence to antihypertensive pharmacotherapy in Buea, Cameroon: a cross-sectional community-based study. BMC Cardiovasc Disord 18(1):1–9CrossRef
13.
Zurück zum Zitat Antignac M, Diop IB, Macquart de Terline D, Kramoh KE, Balde DM, Dzudie A et al (2018) Socioeconomic status and hypertension control in sub-Saharan Africa: the multination eight study (evaluation of hypertension in Sub-Saharan Africa). Hypertension 71(4):577–584CrossRefPubMed Antignac M, Diop IB, Macquart de Terline D, Kramoh KE, Balde DM, Dzudie A et al (2018) Socioeconomic status and hypertension control in sub-Saharan Africa: the multination eight study (evaluation of hypertension in Sub-Saharan Africa). Hypertension 71(4):577–584CrossRefPubMed
14.
Zurück zum Zitat Bilal A, Riaz M, Shafiq N-u, Ahmed M, Sheikh S, Rasheed S (2015) Non-compliance to anti-hypertensive medication and its associated factors among hypertensives. J Ayub Med College Abbottabad. 27(1):158–163 Bilal A, Riaz M, Shafiq N-u, Ahmed M, Sheikh S, Rasheed S (2015) Non-compliance to anti-hypertensive medication and its associated factors among hypertensives. J Ayub Med College Abbottabad. 27(1):158–163
15.
Zurück zum Zitat Mahmood S, Jalal Z, Hadi MA, Orooj H, Shah KU (2020) Non-adherence to prescribed antihypertensives in primary, secondary and tertiary healthcare settings in Islamabad, Pakistan: a cross-sectional study. Patient Preference Adherence 14:73–85CrossRefPubMedPubMedCentral Mahmood S, Jalal Z, Hadi MA, Orooj H, Shah KU (2020) Non-adherence to prescribed antihypertensives in primary, secondary and tertiary healthcare settings in Islamabad, Pakistan: a cross-sectional study. Patient Preference Adherence 14:73–85CrossRefPubMedPubMedCentral
16.
17.
Zurück zum Zitat Weder AB (2011) Treating acute hypertension in the hospital: a Lacuna in the guidelines. Am Heart Assoc 57(1):18–20 Weder AB (2011) Treating acute hypertension in the hospital: a Lacuna in the guidelines. Am Heart Assoc 57(1):18–20
18.
Zurück zum Zitat Campbell P, Baker WL, Bendel SD, White WB (2011) Intravenous hydralazine for blood pressure management in the hospitalized patient: its use is often unjustified. J Am Soc Hypertens 5(6):473–477CrossRefPubMedPubMedCentral Campbell P, Baker WL, Bendel SD, White WB (2011) Intravenous hydralazine for blood pressure management in the hospitalized patient: its use is often unjustified. J Am Soc Hypertens 5(6):473–477CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M et al (2018) 2018 ESC/ESH Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European society of cardiology (ESC) and the European society of hypertension (ESH). Eur Heart J 39(33):3021–3104CrossRefPubMed Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M et al (2018) 2018 ESC/ESH Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European society of cardiology (ESC) and the European society of hypertension (ESH). Eur Heart J 39(33):3021–3104CrossRefPubMed
20.
Zurück zum Zitat Gaynor MF, Wright GC, Vondracek S (2018) Retrospective review of the use of as-needed hydralazine and labetalol for the treatment of acute hypertension in hospitalized medicine patients. Ther Adv Cardiovasc Dis 12(1):7–15CrossRefPubMed Gaynor MF, Wright GC, Vondracek S (2018) Retrospective review of the use of as-needed hydralazine and labetalol for the treatment of acute hypertension in hospitalized medicine patients. Ther Adv Cardiovasc Dis 12(1):7–15CrossRefPubMed
21.
Zurück zum Zitat Allgaier J, Emmich M, Rastegar V, Stefan MS, Lagu T (2020) Hypertensive urgency or emergency? The use of intravenous medications in hospitalized hypertensive patients without organ dysfunction. Heart Lung 49(6):824–828CrossRefPubMed Allgaier J, Emmich M, Rastegar V, Stefan MS, Lagu T (2020) Hypertensive urgency or emergency? The use of intravenous medications in hospitalized hypertensive patients without organ dysfunction. Heart Lung 49(6):824–828CrossRefPubMed
22.
Zurück zum Zitat Karras DJ, Kruus LK, Cienki JJ, Wald MM, Ufberg JW, Shayne P et al (2008) Utility of routine testing for patients with asymptomatic severe blood pressure elevation in the emergency department. Ann Emerg Med 51(3):231–239CrossRefPubMed Karras DJ, Kruus LK, Cienki JJ, Wald MM, Ufberg JW, Shayne P et al (2008) Utility of routine testing for patients with asymptomatic severe blood pressure elevation in the emergency department. Ann Emerg Med 51(3):231–239CrossRefPubMed
23.
Zurück zum Zitat Karras DJ, Kruus LK, Cienki JJ, Wald MM, Chiang WK, Shayne P et al (2006) Evaluation and treatment of patients with severely elevated blood pressure in academic emergency departments: a multicenter study. Ann Emerg Med 47(3):230–236CrossRefPubMed Karras DJ, Kruus LK, Cienki JJ, Wald MM, Chiang WK, Shayne P et al (2006) Evaluation and treatment of patients with severely elevated blood pressure in academic emergency departments: a multicenter study. Ann Emerg Med 47(3):230–236CrossRefPubMed
24.
Zurück zum Zitat Mahmood S, Jalal Z, Hadi MA, Shah KU (2020) Association between attendance at outpatient follow-up appointments and blood pressure control among patients with hypertension. BMC Cardiovasc Disord 20(1):1–11CrossRef Mahmood S, Jalal Z, Hadi MA, Shah KU (2020) Association between attendance at outpatient follow-up appointments and blood pressure control among patients with hypertension. BMC Cardiovasc Disord 20(1):1–11CrossRef
25.
Zurück zum Zitat Nishijima DK, Paladino L, Sinert R (2010) Routine testing in patients with asymptomatic elevated blood pressure in the ED. Am J Emerg Med 28(2):235–242CrossRefPubMed Nishijima DK, Paladino L, Sinert R (2010) Routine testing in patients with asymptomatic elevated blood pressure in the ED. Am J Emerg Med 28(2):235–242CrossRefPubMed
26.
Zurück zum Zitat Patel KK, Young L, Howell EH, Hu B, Rutecki G, Thomas G et al (2016) Characteristics and outcomes of patients presenting with hypertensive urgency in the office setting. JAMA Intern Med 176(7):981–988CrossRefPubMed Patel KK, Young L, Howell EH, Hu B, Rutecki G, Thomas G et al (2016) Characteristics and outcomes of patients presenting with hypertensive urgency in the office setting. JAMA Intern Med 176(7):981–988CrossRefPubMed
27.
Zurück zum Zitat Levy P, Ye H, Compton S, Zalenski R, Byrnes T, Flack JM et al (2012) Subclinical hypertensive heart disease in black patients with elevated blood pressure in an inner city emergency department. Annals emerg medicine. 60(4):467-474.e1CrossRef Levy P, Ye H, Compton S, Zalenski R, Byrnes T, Flack JM et al (2012) Subclinical hypertensive heart disease in black patients with elevated blood pressure in an inner city emergency department. Annals emerg medicine. 60(4):467-474.e1CrossRef
28.
Zurück zum Zitat Landim MP, Cosenso-Martin LN, Santos AP, Uyemura JRR, Fernandes LB, da Silva LV et al (2021) Predictive factors for target organ injuries in hypertensive individuals. Integr Blood Press Control 14:113CrossRef Landim MP, Cosenso-Martin LN, Santos AP, Uyemura JRR, Fernandes LB, da Silva LV et al (2021) Predictive factors for target organ injuries in hypertensive individuals. Integr Blood Press Control 14:113CrossRef
Metadaten
Titel
Clinical utility of routine investigations and risk factors of end-organ damage in asymptomatic severe hypertension
verfasst von
Noman Ali
Umaira Aftab
Salman Muhammad Soomar
Hafsa Tareen
Uzma Rahim Khan
Badar Afzal Khan
Junaid Abdul Razzak
Publikationsdatum
05.09.2023
Verlag
Springer International Publishing
Erschienen in
Internal and Emergency Medicine / Ausgabe 7/2023
Print ISSN: 1828-0447
Elektronische ISSN: 1970-9366
DOI
https://doi.org/10.1007/s11739-023-03403-8

Weitere Artikel der Ausgabe 7/2023

Internal and Emergency Medicine 7/2023 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Battle of Experts: Sport vs. Spritze bei Adipositas und Typ-2-Diabetes

11.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Im Battle of Experts traten zwei Experten auf dem Diabeteskongress gegeneinander an: Die eine vertrat die Auffassung „Sport statt Spritze“ bei Adipositas und Typ-2-Diabetes, der andere forderte „Spritze statt Sport!“ Am Ende waren sie sich aber einig: Die Kombination aus beidem erzielt die besten Ergebnisse.

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

10.05.2024 Hypercholesterinämie Nachrichten

Patienten mit Arteriosklerose-bedingten kardiovaskulären Erkrankungen, die trotz Statineinnahme zu hohe Triglyzeridspiegel haben, profitieren von einer Behandlung mit Icosapent-Ethyl, und zwar unabhängig vom individuellen Risikoprofil.

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

In den USA ist erstmals eine bioresorbierbare Gefäßstütze – auch Scaffold genannt – zur Rekanalisation infrapoplitealer Arterien bei schwerer PAVK zugelassen worden. Das markiert einen Wendepunkt in der Geschichte dieser speziellen Gefäßstützen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.